Working to Eradicate Gynecologic Cancers

Arturo Soto Matos-Pita, MD

Clinical Development Director
PharmaMar SA
Avda. De los Reyes, 1, Pol. Ind. La Mina-Norte, 28770-Colmenar Viejo,
Madrid Spain 28770

Papers:
99 - Featured Poster Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: exploratory analysis of phase III OVA-301 study